Broadfin Capital, LLC Historic Quarter Change: Foreign ADRs, Added

Broadfin Capital, LLC historic quarter change: Foreign ADRs, Added

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 13 quarters from 2013-06-30 to 2016-09-30, Broadfin Capital, LLC opened 7 positions, added to 10, reduced 10 and sold out of 6.

Q1 2016: Stock AMARIN CORP PLC; Country of operation —; Class SPONS ADR NEW; Shares before 4,175,216.
Q3 2015: Stock REDHILL BIOPHARMA LTD; Country of operation —; Class SPONSORED ADS; Shares before 384,281.
Q3 2015: Stock AMARIN CORP PLC; Country of operation —; Class SPONS ADR NEW; Shares before 3,525,216.
Q2 2015: Stock FLAMEL TECHNOLOGIES SA; Country of operation —; Class SPONSORED ADR; Shares before 4,719,959.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1511901), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-28); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2010-12-31.

Quarter	Stock	Class	Shares before	Shares after	Share change	Value before	Value after	Value change	Filed
Q1 2016	AMARIN CORP PLC CUSIP 023111206	SPONS ADR NEW	4,175,216	4,675,216	+500,000	$7,891,000	$7,153,000	-$738,000	2016-05-16
Q3 2015	REDHILL BIOPHARMA LTD CUSIP 757468103	SPONSORED ADS	384,281	829,906	+445,625	$6,767,000	$10,714,000	+$3,947,000	2015-11-16
Q3 2015	AMARIN CORP PLC CUSIP 023111206	SPONS ADR NEW	3,525,216	4,175,216	+650,000	$8,672,000	$8,058,000	-$614,000	2015-11-16
Q2 2015	FLAMEL TECHNOLOGIES SA CUSIP 338488109	SPONSORED ADR	4,719,959	4,975,184	+255,225	$84,865,000	$105,424,000	+$20,559,000	2015-08-14
Q2 2015	AMARIN CORP PLC CUSIP 023111206	SPONS ADR NEW	991,883	3,525,216	+2,533,333	$2,321,000	$8,672,000	+$6,351,000	2015-08-14
Q1 2015	REDHILL BIOPHARMA LTD CUSIP 757468103	SPONSORED ADS	251,509	484,281	+232,772	$3,353,000	$7,046,000	+$3,693,000	2015-05-15
Q4 2014	FLAMEL TECHNOLOGIES SA CUSIP 338488109	SPONSORED ADR	5,005,613	5,153,190	+147,577	$71,630,000	$88,274,000	+$16,644,000	2015-02-17
Q1 2014	FLAMEL TECHNOLOGIES SA CUSIP 338488109	SPONSORED ADR	3,767,911	5,267,911	+1,500,000	$30,332,000	$70,590,000	+$40,258,000	2014-05-15
Q3 2013	FLAMEL TECHNOLOGIES SA CUSIP 338488109	SPONSORED ADR	3,139,131	3,767,911	+628,780	$19,268,000	$24,717,000	+$5,449,000	2013-11-14
Q3 2013	GW PHARMACEUTICALS PLC CUSIP 36197T103	ADS	280,000	332,936	+52,936	$2,467,000	$5,700,000	+$3,233,000	2013-11-14

Similar Firms

Firm Name	Country	13F Value	Holdings
Not available yet